283 related articles for article (PubMed ID: 33890347)
1. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma.
Meng Y; Zhang H; Li Q; Xing P; Liu F; Cao K; Fang X; Li J; Yu J; Feng X; Ma C; Wang L; Jiang H; Lu J; Bian Y; Shao C
J Magn Reson Imaging; 2021 Nov; 54(5):1432-1443. PubMed ID: 33890347
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Radiomics Approach to Evaluating Tumor-Infiltrating CD8
Bian Y; Liu C; Li Q; Meng Y; Liu F; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Zhao Z; Wang L; Xu J; Shao C; Lu J
J Magn Reson Imaging; 2022 Mar; 55(3):803-814. PubMed ID: 34355834
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Tumor-Infiltrating CD20
Li Q; Yu J; Zhang H; Meng Y; Liu YF; Jiang H; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Feng X; Lu J; Shao C; Bian Y
Acad Radiol; 2022 Sep; 29(9):e167-e177. PubMed ID: 34922828
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Radiomics and Machine-learning Models: An Approach for Evaluating Tumor-stroma Ratio in Patients with Pancreatic Ductal Adenocarcinoma.
Meng Y; Zhang H; Li Q; Liu F; Fang X; Li J; Yu J; Feng X; Lu J; Bian Y; Shao C
Acad Radiol; 2022 Apr; 29(4):523-535. PubMed ID: 34563443
[TBL] [Abstract][Full Text] [Related]
5. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting CD20
Yu J; Li Q; Zhang H; Meng Y; Liu YF; Jiang H; Ma C; Liu F; Fang X; Li J; Feng X; Shao C; Bian Y; Lu J
Abdom Radiol (NY); 2022 Jan; 47(1):242-253. PubMed ID: 34708252
[TBL] [Abstract][Full Text] [Related]
7. Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.
Bian Y; Zhao Z; Jiang H; Fang X; Li J; Cao K; Ma C; Guo S; Wang L; Jin G; Lu J; Xu J
J Magn Reson Imaging; 2020 Oct; 52(4):1124-1136. PubMed ID: 32343872
[TBL] [Abstract][Full Text] [Related]
8. Editorial for "Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma".
Sivanesan U; van der Pol CB
J Magn Reson Imaging; 2021 Nov; 54(5):1444-1445. PubMed ID: 33963800
[No Abstract] [Full Text] [Related]
9. Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma.
Bian Y; Liu YF; Jiang H; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Li Q; Wang L; Lu J; Shao C
Abdom Radiol (NY); 2021 Oct; 46(10):4800-4816. PubMed ID: 34189612
[TBL] [Abstract][Full Text] [Related]
10. CT Radiomics and Machine-Learning Models for Predicting Tumor-Stroma Ratio in Patients With Pancreatic Ductal Adenocarcinoma.
Meng Y; Zhang H; Li Q; Liu F; Fang X; Li J; Yu J; Feng X; Zhu M; Li N; Jing G; Wang L; Ma C; Lu J; Bian Y; Shao C
Front Oncol; 2021; 11():707288. PubMed ID: 34820324
[TBL] [Abstract][Full Text] [Related]
11. Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods.
Liu J; Zeng P; Guo W; Wang C; Geng Y; Lang N; Yuan H
J Magn Reson Imaging; 2021 Oct; 54(4):1303-1311. PubMed ID: 33979466
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
[TBL] [Abstract][Full Text] [Related]
13. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.
Shi Z; Ma C; Huang X; Cao D
J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
[TBL] [Abstract][Full Text] [Related]
15. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.
Li Q; Zhou Z; Chen Y; Yu J; Zhang H; Meng Y; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Wang T; Lu J; Zhang T; Xu J; Shao C; Bian Y
Abdom Radiol (NY); 2023 Jun; 48(6):2074-2084. PubMed ID: 36964775
[TBL] [Abstract][Full Text] [Related]
16. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R
Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935
[TBL] [Abstract][Full Text] [Related]
17. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning.
Yuan Z; Shu Z; Peng J; Wang W; Hou J; Han L; Zheng G; Wei Y; Zhong J
Abdom Radiol (NY); 2024 Jan; 49(1):117-130. PubMed ID: 37819438
[TBL] [Abstract][Full Text] [Related]
18. MRI-Based Back Propagation Neural Network Model as a Powerful Tool for Predicting the Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Liao H; Chen X; Lu S; Jin G; Pei W; Li Y; Wei Y; Huang X; Wang C; Liang X; Bao H; Liu L; Su D
J Magn Reson Imaging; 2022 Aug; 56(2):547-559. PubMed ID: 34970824
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions.
Deng Y; Ming B; Zhou T; Wu JL; Chen Y; Liu P; Zhang J; Zhang SY; Chen TW; Zhang XM
Front Oncol; 2021; 11():620981. PubMed ID: 33842325
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients.
Huang Y; Zhou S; Luo Y; Zou J; Li Y; Chen S; Gao M; Huang K; Lian G
Radiat Oncol; 2023 May; 18(1):79. PubMed ID: 37165440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
